A aderencia se fundamentou na reposta do paciente, que era comparada com a receita e com as notas da evoluc;;aoclfnica. Foi considerado erroquando 0 ...
Its complexity begins with the difficulty in adopting terminology that can express its exact meaning. Moreover, many methods to evaluate compliance have.
1Department of Biochemistry, Isfahan Cardiovascular Research Institute, Isfahan ... the treatment of individual components of the MetS in a population-based ...
guardians with the pharmacy dispensing records at the service, every 4 months ... weak correlation with pharmacy records during the period studied; fourth (r ...
their perception of compliance, and their ... Patients reporting immediate bene- .... "do you have help with your physiotherapy," ...... doi: 10.1136/thx.49.2.115.
Dec 19, 2016 - meta-analysis on lisdexamfetamine confirmed a large effect over placebo on ADHD symptoms (SMD â0.97, 95% CI â1.15 to â0.78).20.
Jun 1, 2011 - methylation of proteins by PMRT and impaired metabolism of DDAH due to shear stress that increases PRMT whithout change in DDAH activity ...
2 Michael White Diabetes Centre, 220-236 Analby Road, Hull Royal Infirmary, Hull HU3 2JZ, ..... [51] R. Fleming, Z. E. Hopkinson, A. Michael Wallace, I. A. Greer,.
This study was sponsored by Amgen (Europe) GmbH and GlaxoSmithKline. Editing support was provided by Claire Desborough of Amgen (Europe) GmbH.
tion medication, and having social support from family members or friends who were concerned about .... are also registered patent medicine stores (pharma-.
adherence rate reported for depot medication is ... targets for future interventions, treatment planning ... nonadherence is poor and interventions to improve.
rates of compliance with beclomethasone treatment reported by parents or guardians with those .... Means were calculated together with their respective 95%.
Mar 9, 2008 - Index was > 30 kg/m2, central obesity was assumed and ... according to their Body Mass Index (BMI). In Step 4, data ..... São Paulo: Ipex. 1997 ...
Jun 11, 2008 - Metabolic syndrome patient compliance with drug treatment. Clinics. 2008;63(5):573-80. OBJECTIVES: 1) To evaluate the compliance with ...
tion of estimated glomerular filtration rate compared to valsartan in the phase II PARAMOUNT trial in heart fail- ure patients with preserved ejection fraction [14, ...
Maintenance therapy in bipolar disorder (BD) is usually required to prevent relapses and improve re- sidual symptoms. ... recruited a cohort of 739 consecutive out-patients with clinically stable BD. Clinical stability was .... Descriptive lists of.
Jul 17, 2012 - of postmenopausal osteoporosis [81]. The cathepsin K inhibitor odanacatib is in advanced development in osteo- porosis studies [82]. Eur Arch ...
A systematic review of definitions of TRD used in clinical trials (Berlim and Turecki 2007b) ... definition will define TRD for clinical registration studies of (new) ...
Archives of Psychiatry and Psychotherapy, 2009 ; 3 : 5â9 ... phasized that psychiatrists should abandon ârig- ..... European multicentre randomised controlled.
May 14, 2013 - The uncritical use of tetrabenazine in doses of âup to 100 mg/day,â as recommended in the guideline, also is not clinically established practice.4 ...
calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol. 2001 Apr; 144(4):894-7. 17. ABDALLAH-LOTF M, GRASLAND ...
Dec 22, 2009 - Acid suppressive medication Gastroesophageal reflux disease Pantoprazole Proton pump inhibitor. Chronic use On-demand therapy Quality of ...
Associate Professor Rajesh Balkrishnan, Co-Chair. Assistant Professor Daniel Eisenberg, Co-Chair. Professor Dean G. Smith. Associate Professor Steven R.
observed in STAR*D (Rush et al., 2006;Ruhe et al., 2006). This definition assumes that treatment with drugs from the same class of antidepressants are less ...
... falores socioeconomicos (residencia, meio de transporle. nivel educacional, condic;;ao ... Eisen SA, MillerDK, Woodward RS, Spitznagel E, PI-Lybeck. TR.
Paulo Roberto Chizzola, Alfredo Jose Mansur, Protasio Lemos da Luz, Giovanni Bellotti
Compliance with pharmacological treatment in outpatients from a Brazilian cardiology referral center Instituto do Corafao, Hospital das Clinicas, University of Sao Paulo - Sao Paulo, Brazil
To evaluate the degree of compliance with pharmacological therapy, and to identify predictors of non-compliance in outpatients from a cardiology referral center in Sao Paulo, Brazil, we studied 485 outpatients, 230 (47.4 percent) males and 255 (52.6 percent) females, through an interview guided by a questionnaire during medical consultation. The ages ranged between 17 and 86 (mean 54, standard deviation 15) years. Heart disease and socioeconomic factors (residence, means of transport, educational level and professional status) were studied. In addition, we examined the drugs prescribed including: difficulties in taking them; the source of supply; and the patient's knowledge of the drugs. Assessment of compliance was based on the patients' response. The patients' answers were compared with the prescription and progress notes. Errors were recorded if the patient reported using one or more nonprescribed medicines. Compliance with therapy was recorded if the patient said the prescription was taken correctly without interruption and without error. The variables with significant differences in univariate analysis were further analyzed by multivariate log-linear regression analysis. Noncompliance occurred in 286 (59 percent) of the patients, and was predicted by the reported difficulty in taking medication (P
